Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laine J Murphey

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2004
Loss of sodium modulation of plasma kinins in human hypertensionLaine J Murphey, Wendy K Eccles, Gordon H Williams, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Effect of combined AT1 receptor and aldosterone receptor antagonism on plasminogen activator inhibitor-1Pairunyar Sawathiparnich, Laine J Murphey, Sandeep Kumar, et al.
Circulation|December 6, 2003
Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypassMias Pretorius, Laine J Murphey, Julie A McFarlane, et al.
Clinical Pharmacology and Therapeutics|December 3, 2005
A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypassMias Pretorius, Frank G Scholl, Julie A McFarlane, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 17, 2005
Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in menMias Pretorius, James M Luther, Laine J Murphey, et al.
Clinical Pharmacology and Therapeutics|October 8, 2004
Angiotensin-converting enzyme inhibition and smoking potentiate the kinin response to cardiopulmonary bypassMias Pretorius, Julie A McFarlane, Douglas E Vaughan, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2006
Bradykinin B(2) receptor does not contribute to blood pressure lowering during AT(1) receptor blockadeJean LeFebvre, Ayumi Shintani, Tebeb Gebretsadik, et al.
The Journal of Biological Chemistry|November 17, 2006
Urinary prostaglandin F2alpha is generated from the isoprostane pathway and not the cyclooxygenase in humansHuiyong Yin, Ling Gao, Hsin-Hsiung Tai, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2002
Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedemaJean Lefebvre, Laine J Murphey, Tina V Hartert, et al.
Free Radical Biology & Medicine|October 30, 2003
Acute angiotensin II increases plasma F2-isoprostanes in salt-replete human hypertensivesLaine J Murphey, Jason D Morrow, Pairunyar Sawathiparnich, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2004
Loss of sodium modulation of plasma kinins in human hypertensionLaine J Murphey, Wendy K Eccles, Gordon H Williams, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Effect of combined AT1 receptor and aldosterone receptor antagonism on plasminogen activator inhibitor-1Pairunyar Sawathiparnich, Laine J Murphey, Sandeep Kumar, et al.
Circulation|December 6, 2003
Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypassMias Pretorius, Laine J Murphey, Julie A McFarlane, et al.
Clinical Pharmacology and Therapeutics|December 3, 2005
A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypassMias Pretorius, Frank G Scholl, Julie A McFarlane, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 17, 2005
Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in menMias Pretorius, James M Luther, Laine J Murphey, et al.
Clinical Pharmacology and Therapeutics|October 8, 2004
Angiotensin-converting enzyme inhibition and smoking potentiate the kinin response to cardiopulmonary bypassMias Pretorius, Julie A McFarlane, Douglas E Vaughan, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2006
Bradykinin B(2) receptor does not contribute to blood pressure lowering during AT(1) receptor blockadeJean LeFebvre, Ayumi Shintani, Tebeb Gebretsadik, et al.
The Journal of Biological Chemistry|November 17, 2006
Urinary prostaglandin F2alpha is generated from the isoprostane pathway and not the cyclooxygenase in humansHuiyong Yin, Ling Gao, Hsin-Hsiung Tai, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2002
Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedemaJean Lefebvre, Laine J Murphey, Tina V Hartert, et al.
Free Radical Biology & Medicine|October 30, 2003
Acute angiotensin II increases plasma F2-isoprostanes in salt-replete human hypertensivesLaine J Murphey, Jason D Morrow, Pairunyar Sawathiparnich, et al.
Pageof 3